Using deep neural networks along with dimensionality reduction techniques to assist the diagnosis of neurodegenerative disorders
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 11, 2018
- Source ID
- 10.1093/jigpal/jzy026
Entities
People
- F J Martinez-murcia
- F Segovia
- J M Górriz
- Juan Marcos Ramírez
- M García-pérez
Organizations
- Alzheimer's Disease Neuroimaging Initiative
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Bristol-Myers Squibb
- Canadian Institutes of Health Research
- Chiron Corporation
- Eli Lilly and Company
- GE HealthCare
- Hoffmann-La Roche
- Innogenetics
- Johnson & Johnson Pharmaceutical Research and Development
- Medpace
- Meso Scale Diagnostics (United States)
- Ministry of Economy, Industry and Competitiveness
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Northern California Institute for Research and Education
- Pfizer
- United States Department of Defense
- University of California
- University of Granada